Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 7851-7900 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03870360
Preventing Anxiety and Depression in Older Hispanics
NAActive, not recruiting
240 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2026
2 conditions2 sponsors1 location
NCT05817396
Dissemination of Physical Activity-related Health Competence in Vocational Education of Nursing Care
NAActive, not recruiting
640 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2025
5 conditions3 sponsors1 location
NCT06520761
The Effect of Injectable PRF Vs LLL on Orthodontic Tooth Movement
NAActive, not recruiting
20 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2024
2 conditions1 sponsor1 location
NCT05678101
TENS for Relief of Postoperative Pain in Orthopedic Patients
NAActive, not recruiting
30 participants
Started: Nov 1, 2022 · Completed: Dec 30, 2025
5 conditions1 sponsor1 location
NCT05601232
A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
PHASE2Active, not recruiting
10 participants
Started: Nov 1, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT05573113
Comparative Effectiveness Trial for Diagnosis of Necrotizing Enterocolitis
NAActive, not recruiting
182 participants
Started: Nov 1, 2022 · Completed: Aug 30, 2025
1 condition3 sponsors2 locations
NCT05403138
Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
PHASE2/PHASE3Active, not recruiting
135 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT05363280
Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC
PHASE2Active, not recruiting
36 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT05559892
Conditional Cash Transfer Intervention to Improve T2DM
NAActive, not recruiting
100 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05781399
First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria
PHASE1/PHASE2Active, not recruiting
135 participants
Started: Oct 31, 2022 · Completed: Dec 15, 2025
1 condition1 sponsor15 locations
NCT04933539
Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
PHASE2Active, not recruiting
14 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2032
1 condition2 sponsors1 location
NCT05127161
Broad Implementation of Outpatient Stewardship
NAActive, not recruiting
1,032 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
4 conditions8 sponsors5 locations
NCT05437263
A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis
PHASE3Active, not recruiting
241 participants
Started: Oct 31, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor109 locations
NCT05325281
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
PHASE1Active, not recruiting
8 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2025
1 condition3 sponsors1 location
NCT05585320
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
209 participants
Started: Oct 31, 2022 · Completed: Jun 30, 2027
4 conditions1 sponsor20 locations
NCT05098444
Efficacy of Internet-based Cognitive Behavioral Therapy for Endometriosis
NAActive, not recruiting
120 participants
Started: Oct 31, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05520476
Neuroliten MVP System Clinical Observation Study
N/AActive, not recruiting
20 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04283513
Treatment of Hemorrhagic Fever With Ribavirin
PHASE2Active, not recruiting
50 participants
Started: Oct 31, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05607745
Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study
NAActive, not recruiting
54 participants
Started: Oct 30, 2022 · Completed: Dec 31, 2026
9 conditions6 sponsors3 locations
NCT06291129
Gingival Health and Malocclusion Among Type 1 Diabetic Children and Adolescents
NAActive, not recruiting
36 participants
Started: Oct 30, 2022 · Completed: Oct 30, 2024
6 conditions1 sponsor1 location
NCT05579184
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2
PHASE2Active, not recruiting
20 participants
Started: Oct 30, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05396859
Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemia
PHASE1Active, not recruiting
13 participants
Started: Oct 28, 2022 · Completed: Jun 30, 2026
3 conditions4 sponsors1 location
NCT05529108
Glycaemic Control Effect of BSG and Underlying Gut - Related Mechanism in Singapore Adults With Metabolic Syndrome
NAActive, not recruiting
38 participants
Started: Oct 28, 2022 · Completed: Sep 30, 2024
2 conditions2 sponsors1 location
NCT05389449
A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH
PHASE3Active, not recruiting
80 participants
Started: Oct 28, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor45 locations
NCT05562271
Clinical Trial of Low-dose Radiation Therapy in Patients With Knee Osteoarthritis (LoRD-KNeA Trial)
NAActive, not recruiting
114 participants
Started: Oct 28, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors3 locations
NCT05784142
Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)
PHASE2Active, not recruiting
55 participants
Started: Oct 27, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05626504
Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
N/AActive, not recruiting
50 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2025
3 conditions1 sponsor1 location
NCT05434156
ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression
PHASE1/PHASE2Active, not recruiting
84 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2026
3 conditions2 sponsors2 locations
NCT05522231
Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)
PHASE2/PHASE3Active, not recruiting
265 participants
Started: Oct 27, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor48 locations
NCT05589389
Meat and Dietary Pattern Study
NAActive, not recruiting
60 participants
Started: Oct 26, 2022 · Completed: Jul 30, 2025
1 condition2 sponsors1 location
NCT05597358
Efficacy of High Intensity Laser for Provoked Vestibulodynia
NAActive, not recruiting
142 participants
Started: Oct 26, 2022 · Completed: Nov 1, 2025
1 condition5 sponsors4 locations
NCT05237804
Evaluation of an Intervention to Reduce the Time to Treatment for TAVI Patients
NAActive, not recruiting
748 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05284747
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
PHASE4Active, not recruiting
6,019 participants
Started: Oct 26, 2022 · Completed: May 29, 2027
4 conditions2 sponsors120 locations
NCT05337514
Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)
NAActive, not recruiting
137 participants
Started: Oct 26, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors1 location
NCT05519865
A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC
PHASE2Active, not recruiting
118 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05120271
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
PHASE1/PHASE2Active, not recruiting
7 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2042
4 conditions3 sponsors8 locations
NCT05481151
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
PHASE3Active, not recruiting
111 participants
Started: Oct 26, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor23 locations
NCT05638087
Dexamethasone Treatment for OSA in Children
PHASE3Active, not recruiting
10 participants
Started: Oct 26, 2022 · Completed: Aug 30, 2025
1 condition1 sponsor1 location
NCT05031819
Managing Hypertension Among People Living with HIV
NAActive, not recruiting
960 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT05340686
Braining- Aerobic Physical Activity As Add on Treatment in Bipolar Depression
NAActive, not recruiting
54 participants
Started: Oct 26, 2022 · Completed: Apr 20, 2027
6 conditions2 sponsors1 location
NCT05620862
Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors
PHASE1Active, not recruiting
68 participants
Started: Oct 25, 2022 · Completed: Jun 1, 2025
1 condition2 sponsors1 location
NCT04953754
Melatonin and Vaccine Response, Immunity, and Chronobiology Study
NAActive, not recruiting
200 participants
Started: Oct 25, 2022 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT05409976
The GORE® VIAFORT Vascular Stent IVC Study
NAActive, not recruiting
112 participants
Started: Oct 25, 2022 · Completed: May 31, 2030
10 conditions1 sponsor17 locations
NCT05556239
STAY-STRONG Study of Exercise Training During Chemotherapy
NAActive, not recruiting
42 participants
Started: Oct 25, 2022 · Completed: Sep 1, 2025
9 conditions1 sponsor1 location
NCT05461885
Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial
NAActive, not recruiting
400 participants
Started: Oct 25, 2022 · Completed: Jan 31, 2026
2 conditions3 sponsors4 locations
NCT05599191
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
PHASE3Active, not recruiting
825 participants
Started: Oct 25, 2022 · Completed: May 28, 2026
2 conditions1 sponsor191 locations
NCT05644756
Novel Methods for Implementing Measurement-Based Care for Youth in Low-resource Environments
NAActive, not recruiting
76 participants
Started: Oct 25, 2022 · Completed: Aug 31, 2025
1 condition3 sponsors1 location
NCT05453968
Berotralstat Treatment in Children With Hereditary Angioedema
PHASE3Active, not recruiting
29 participants
Started: Oct 25, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor15 locations
NCT05479994
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2Active, not recruiting
100 participants
Started: Oct 24, 2022 · Completed: Aug 25, 2027
5 conditions1 sponsor50 locations
NCT05465096
Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.
NAActive, not recruiting
30 participants
Started: Oct 24, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location